[Neuropathophysiological and neuroimmunopathological approaches to understanding the mechanisms and establishing the principles of the pathogenetic therapy of alcoholism].
D000437:Alcoholism / Q000209:etiology / Q000628:therapy*; D000818:Animals; D014151:Anti-Anxiety Agents; D001323:Autoantibodies / Q000096:biosynthesis; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use*; D006220:Haloperidol / Q000627:therapeutic use*; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D007167:Immunotherapy; D051379:Mice; D008810:Mice, Inbred C57BL; D018377:Neurotransmitter Agents / Q000276:immunology / Q000378:metabolism; D009942:Organometallic Compounds / Q000627:therapeutic use*; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000378:metabolism
D014151:Anti-Anxiety Agents; D001323:Autoantibodies; D001570:Benzodiazepinones; D006885:Hydroxybutyrates; D018377:Neurotransmitter Agents; D009942:Organometallic Compounds; D017981:Receptors, Neurotransmitter; D001569:Benzodiazepines; C017928:phenazepam; C022826:lithium hydroxybutyrate; D006220:Haloperidol
Neĭropatofiziologicheskiĭ i neĭroimmunopatologicheskiĭ podkhody k ponimaniiu mekhanizmov i razrabotke printsipov patogeneticheskoĭ terapii alkogolizma.